Jubilant Life Sciences has informed that a meeting of the Board of Directors of the Company will be held on May 07, 2013, to consider : Audited Financial Results of the Company for the year ended March 31, 2013 ,Recommendation of Dividend for the Year ended March 31, 2013.
The above information is a part of company’s filings submitted to BSE.